Scutellarin inhibits cell migration by regulating production of αvβ6 integrin and E-cadherin in human tongue cancer cells

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1153-1160

  Li, Haixia ^a   Huang, Dayong ^a   Gao, Zhongxiuzi ^a   Lv, Yanhong ^a   Zhang, Lina ^a   Cui, Haidong ^a   Zheng, Jinhua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

v 6 integrin; Adhesion; E cadherin; Oral squamous cell carcinoma; Scutellarin

Indexed keywords

ALPHAVBETA6 INTEGRIN; ANTINEOPLASTIC AGENT; DESMOPLAKIN; FIBRONECTIN; MESSENGER RNA; SCUTELLARIN; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; UPREGULATION; WOUND HEALING;

ANTIGENS, NEOPLASM; APIGENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIC ACIDS; HUMANS; INTEGRINS; RNA, MESSENGER; TONGUE NEOPLASMS;

EID: 78149328322     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000967     Document Type: Article

References (35)

1. Lippman SM, Sudbo J and Hong WK: Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23: 346-356, 2005. (Pubitemid 46206883)
2. Miyazaki Y, Hara A, Kato K, et al: The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma. Int J Oncol 32: 145-151, 2008.
3. Myoung H, Kim MJ, Hong SD, Lee JI, Lim CY and Hong SP: Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett 185: 201-209, 2002.
4. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
5. Takeichi M: Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59: 237-252, 1990.
6. Moles JP and Watt FM: The epidermal stem cell compartment: Variation in expression levels of E-cadherin and catenins within the basal layer of human epidermis. J Histochem Cytochem 45: 867-874, 1997.
7. Frixen U, Behrens J, Sachs M, et al: E-cadherin-mediated cellcell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
8. Kowalski PJ, Rubin MA and Kleer CG: E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: R217-R222, 2003.
9. Umbas R, Isaacs W, Bringuier P, et al: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933, 1994.
10. Winter JM, Ting AH, Vilardell F, et al: Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 14: 412-418, 2008.
11. Dorudi S, Hanby AM, Poulsom R, Northover J and Hart IR: Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71: 614-616, 1995.
12. Huang MF, Zhu YQ, Chen ZF, et al: Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. World J Gastroenterol 11: 2975-2980, 2005.
13. Mialhe A, Levacher G, Champelovier P, et al: Expression of E-, P-, N-cadherins and catenins in human bladder carcinoma cell lines. J Urol 164: 826-835, 2000.
14. Jiao W, Miyazaki K and Kitajima Y: Inverse correlation between E-cadherin and snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86: 98-101, 2002.
15. Andrews NA, Jones AS, Helliwell TR and Kinsella AR: Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75: 1474-1480, 1997.
16. Kudo Y, Kitajima S, Ogawa I, et al: Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 10: 5455-5463, 2004.
17. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
18. Breuss JM, Gallo J, DeLisser HM, et al: Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 108: 2241-2251, 1995.
19. Hamidi S, Salo T, Kainulainen T, Epastein J, Lerner K and Larjava H: Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer 82: 1433-1440, 2000.
20. Regezi JA, Ramos DM, Pytela R, Dekker NP and Jordan RC: Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38: 332-336, 2002.
21. Impola U, Uitto VJ, Hietanen J, et al: Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202: 14-22, 2004.
22. Thomas GJ, Lewis MP, Whawell SA, et al: Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 117: 67-73, 2001.
23. Suh SJ, Yoon JW, Lee TK, et al: Chemoprevention of scutellaria barbata on human cancer cells and tumorigenesis in skin cancer. Phytoth Res 21: 135-141, 2007.
24. Goh D, Lee YH and Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 53: 8197-8204, 2005.
25. Jing G-P, Jiao X-H, Wang X-Y, et al: Anticancer activity and mechanism of total flavonoids extracted from Scutellaria barbata on human tongue cancer cell line SAS. J Oral Sci Res 25: 249-253, 2009.
26. Pan L: Quantitative determination of scutellarin in Kang' aiping pills by HPLC. China Pharmacy 19: 203-204, 2008 (In Chinese).
27. Luo P, Tan ZH, Zhang ZF, Zhang H, Liu XF and Mo ZJ: Scutellarin isolated from erigeron multiradiatus inhibits high glucose-mediated vascular inflammation. Yakugaku Zasshi 128: 1293-1299, 2008.
28. Xu W, Zha RP, Wang WY and Wang YP: Effects of scutellarin on PKC gamma in PC12 cell injury induced by oxygen and glucose deprivation. Acta Pharmacol Sin 28: 1573-1579, 2007.
29. Schechtman D and Mochly-Rosen D: Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339-6347, 2001.
30. + proliferation index correlates with increased cellular retinolbinding protein-1 and the coordinated loss of plakophilin-1 and desmoplakin during progression of cervical squamous lesions. Histopathology 51: 87-97, 2007.
31. Papagerakis S, Shabana AH, Pollock BH, Papagerakis P, Depondt J and Berdal A: Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer. Hum Pathol 40: 1320-1329, 2009.
32. Bankfalvi A, Krassort M, Vegh A, Felszeghy E and Piffko J: Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31: 450-457, 2002.
33. Liu H, Chen B, Zardi L and Ramos D: Soluble fibronectin promotes migration of oral squamous-cell carcinoma cells. Int J Cancer 78: 261-267, 1998.
34. Busk M, Pytela R and Sheppard D: Characterization of the integrin alphavbeta6 as a fibronectin-binding protein. J Biol Chem 267: 5790-5796, 1992.
35. Huang X, Wu J, Spong S and Sheppard D: The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci 111: 2189-2195, 1998.